iRhythm Technologies, Inc. (IRTC) Touches $70.41 High on May, 18; COMPUTERSHARE LTD AUD 0.20 ORDINARY SHAR (CMSQF) Shorts Increased By 2.4%

May 18, 2018 - By Adrian Erickson

Computershare Limited (OTCMKTS:CMSQF) Logo

COMPUTERSHARE LTD AUD 0.20 ORDINARY SHAR (OTCMKTS:CMSQF) had an increase of 2.4% in short interest. CMSQF’s SI was 857,700 shares in May as released by FINRA. Its up 2.4% from 837,600 shares previously. The SI to COMPUTERSHARE LTD AUD 0.20 ORDINARY SHAR’s float is 0.17%. It closed at $13.84 lastly. It is down 0.00% since May 18, 2017 and is . It has underperformed by 11.55% the S&P500.




The stock of iRhythm Technologies, Inc. (NASDAQ:IRTC) reached all time high today, May, 18 and still has $73.93 target or 5.00% above today’s $70.41 share price. This indicates more upside for the $1.66B company. This technical setup was reported by Barchart.com. If the $73.93 PT is reached, the company will be worth $83.10M more. The stock increased 3.29% or $2.24 during the last trading session, reaching $70.41. About 186,317 shares traded. iRhythm Technologies, Inc. (NASDAQ:IRTC) has risen 69.09% since May 18, 2017 and is uptrending. It has outperformed by 57.54% the S&P500.

More notable recent iRhythm Technologies, Inc. (NASDAQ:IRTC) news were published by: Nasdaq.com which released: “JAMA Cardiology publishes RHYTHM Study Revealing Link Between Total AF Burden and Stroke Risk” on May 16, 2018, also Streetinsider.com with their article: “iRhythm Technologies (IRTC) Says JAMA Cardiology published RHYTHM Study Revealing Link Between Total AF …” published on May 16, 2018, Globenewswire.com published: “iRhythm Technologies Announces First Quarter Financial Results” on May 02, 2018. More interesting news about iRhythm Technologies, Inc. (NASDAQ:IRTC) were released by: Seekingalpha.com and their article: “iRhythm Technologies’ (IRTC) CEO Kevin King on Q1 2018 Results – Earnings Call Transcript” published on May 05, 2018 as well as Benzinga.com‘s news article titled: “Benzinga’s Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer’s Trial …” with publication date: May 10, 2018.

Analysts await iRhythm Technologies, Inc. (NASDAQ:IRTC) to report earnings on August, 1. They expect $-0.41 EPS, down 41.38% or $0.12 from last year’s $-0.29 per share. After $-0.47 actual EPS reported by iRhythm Technologies, Inc. for the previous quarter, Wall Street now forecasts -12.77% EPS growth.

iRhythm Technologies, Inc., a digital healthcare company, focuses on the provision of ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias in the United States. The company has market cap of $1.66 billion. It offers ZIO Service, a platform that provides wearable biosensor with cloud data analytics that distill data from heartbeats into clinically actionable information. It currently has negative earnings.

iRhythm Technologies, Inc. (NASDAQ:IRTC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: